ArticleJournal of materials science. Materials in medicine2025
Machine learning-based fabrication of phytogenic NiO nanoparticles for anticancer activity in HepG2 Cell Culture.
Article in Journal of materials science. Materials in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Implications of the molecular toxicity and cytocompatibility by the nano-caged CNaunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Green Synthesis of Platinum Nanoparticles Using Aqueous Broccoli Extract for Antimicrobial, Antioxidant, Wound Healing, Antidiabetic, and Anticancer Applications.Cell biochemistry and biophysics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal oxide nanomaterials play a central role in biomedical applications due to their unique physicochemical properties. In particular, various treatment methods such as drug delivery, hyperthermia therapy, radiation, and chemotherapy are used for the treatment of carcinoma. Current studies prefer to investigate the anticancer activity of nickel oxide nanoparticles were synthesized using a green synthesis approach. The X-ray diffraction (XRD) analysis was used to investigate the cubic crystalline structure and crystallite size varies from 11.08 nm to 12.88 nm due to increased calcination temperature. The crystallite size has a significant impact on the cytotoxicity and toxicity of nanoparticles; smaller crystal sizes frequently result in higher toxicity, because of their larger surface area to volume ratio. The MTT (Tetrazolium salts) assay was performed to test the cytotoxicity of NiO nanoparticles (NPs) against HepG2 cell line. After that, machine learning was applied to connect the biomedical field with artificial intelligence. It can be seen from the results that the NiO NPs that were calcinated at 600 °C gave the average cell viability <40%. At last, the machine learning approach was used to calculate the cytotoxicity of NiO NPs and decision tree was generated by using Google Colab. A correlation matrix was generated using a machine learning approach, providing insights into the interdependence among all parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.